The markets are reacting to comments from Fed Chair Jerome Powell, who announced a plan to taper its asset purchases faster. He--and the rest of the economist community--is ready to retire the word “transitory,” but his comments have not retired questions and concerns from investors. CNBC’s Steve Liesman explains Powell’s comments. CEO of Lazard’s Financial Advisory business Peter Orszag discusses Fed leadership and Lazard’s efforts to quantify climate issues in the equities market. The FDA has narrowly endorsed Merck’s oral Covid treatment pill; former FDA Commissioner Dr. Scott Gottlieb discusses therapeutics, vaccine efficacy against the omicron variant, and Covid-19’s evolution. Plus, how much do you love Tesla? Enough for a tattoo? In this episode:Dr. Scott Gottlieb, @ScottGottliebMDPeter Orszag, @porszagSteve Liesman, @SteveLiesmanJoe Kernen, @JoeSquawkBecky Quick, @BeckyQuickAndrew Ross Sorkin, @andrewrsorkinKatie Kramer, @Kramer_Katie